Company intelligence / Profile preview

Nanochon

Washington, District of Columbia, United Statesnanochon.com ↗

Ownership: Private
Employees: ~25
Development stage: Preclinical

Overview

Nanochon has demonstrated strong results in animal studies with its Chondrograft™ device—a minimally invasive, load-bearing orthopedic implant that also serves as a tissue growth scaffold. The company began its first-in-human feasibility study for the device in early/mid–2025. The initial trial will evaluate safety and early efficacy outcomes. Plans are underway to scale manufacturing for a randomized pivotal trial targeting FDA approval and commercialization by around 2029.

Therapeutic areas: Rheumatology
Modalities: DeviceNanoparticle (nanomaterial-based implant)Scaffold-based therapy (tissue growth scaffold)
Industry: Implantable Medical Devices

Drug pipeline

1 asset

Chondrograft

Pre-clinical

Indications: Cartilage damage, Joint injury

Partnerships

LaunchPort (early-stage medtech manufacturing partner)University of Virginia Licensing & Ventures Group Seed Fund (investor/partner)

Beyond the preview

Go deeper on Nanochon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanochon.

Explore the full profile